Side-by-side comparison of AI visibility scores, market position, and capabilities
Phoenix BC Partners-owned largest North American specialty pet retailer at $10B FY2023 revenue with 1,500+ stores, Banfield vet clinics, and Chewy equity stake competing with Petco and Chewy for pet care market share.
PetSmart is a Phoenix, Arizona-based specialty pet retail chain — privately held since BC Partners' $8.7 billion leveraged buyout in 2015 — operating 1,500+ stores across the United States, Canada, and Puerto Rico as the largest specialty pet retailer in North America, generating approximately $10 billion in revenue in fiscal year 2023 (with Q3 2024 sales of $1.50 billion, +8% year-over-year), serving pet owners with an integrated retail, services, and healthcare ecosystem that includes pet food and supplies, grooming salons, PetsHotel boarding and day camp, Banfield Pet Hospital veterinary clinics (an in-store Mars Inc. franchise), dog training classes, and adoption events partnering with local rescue organizations and shelters. PetSmart holds a significant equity stake in Chewy, Inc. (NYSE: CHWY), having acquired Chewy in 2017 for $3.35 billion before Chewy's 2019 IPO.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.